Bio-Rad Laboratories Inc. (NYSE: BIO) reported Q4 EPS of $2.08, $0.41 better than the analyst estimate of $1.67. Revenue for the quarter came in at $550.2 million versus the consensus estimate of $562.06 million.

For earnings history and earnings-related data on Bio-Rad Laboratories Inc. (BIO) click here.

Earnings